AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Etoricoxib in Nigeria
10 products registered with NAFDAC — 7 active, 3 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Etoget Tablet 120 mg Tablet | A4-101142 | Getz Pharma Nigeria Limited | active | 29 Jan 2030 |
| Etoget Tablet 60 mg Tablet | A4-101147 | Getz Pharma Nigeria Limited | active | 29 Jan 2030 |
| Etoget Tablet 90 mg** Tablet | A4-100905 | Getz Pharma Nigeria Limited | active | 26 Jun 2029 |
| Etrobax 60 Tablets Tablet | A4-100754 | Hetero Labs Nigeria Limited | active | 27 Feb 2029 |
| Etrobax 90 Tablets Tablet | A4-100648 | Hetero Labs Nigeria Limited | active | 20 Dec 2028 |
| Etostal 120 Tablet Tablet | C4-1365 | Onifam Laboratories Limited | active | 20 Dec 2025 |
| Etostal 90 Tablet Tablet | C4-1364 | Onifam Laboratories Limited | active | 20 Dec 2025 |
| ETOCOXX 60MG TABLETS/ 1 X 7 | B4-6702 | RANBAXY NIG LTD PLOT 5 | expired | 10 Jan 2022 |
| ETOCOXX 120MG TABLETS/ 1 X 7 | B4-6704 | RANBAXY NIG LTD PLOT 5 | expired | 10 Jan 2022 |
| ETOCOXX 90MG TABLETS/ 1 X 7 | B4-6703 | RANBAXY NIG LTD PLOT 5 | expired | 10 Jan 2022 |
Etoricoxib — NAFDAC Registration Details
NAFDAC (Nigeria) has 10 registered products containing Etoricoxib, of which 7 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Etoricoxib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.